Celgene (CELG)

Add to Watchlists Create an Alert
87.73 +0.09  +0.10% NASDAQ Jul 29, 8:00PM BATS Real time Currency in USD
View Full Chart
CELG Price Chart
View All Events

CELG Events

Date Type Description
06/26/2014 Splits Ratio: 2:1
04/24/2014 09:00 EDT Misc Q1 2014 Celgene Corporation Earnings Conference Call
04/24/2014 Earnings Q1 2014 Celgene Corporation Earnings Results. Estimate: 1.43.
01/30/2014 09:00 EDT Misc Q4 2013 Celgene Corp. Earnings Conference Call
01/30/2014 Earnings Q4 2013 Celgene Corp. Earnings Result. Estimate: 1.39.
10/24/2013 09:00 EDT Misc Will Host an Investor Webcast Event From the American College of Rheumatology Meeting on October 27, 2013 Summit, n.j.--(business Wire)--oct. 1, 2013-- Celgene Corporation (Nasdaq:celg) Will Host a Conference Call and Live Audio Webcast on Thursday,
10/24/2013 Earnings Celgene Corporation to Announce Third Quarter 2013 Results on October 24, 2013. Estimate: 1.38.
View All Performance Charts

CELG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celgene is up 21.91% over the last year vs S&P 500 Total Return up 18.90%, Amgen up 20.90%, and Gilead Sciences up 48.63%.

Get Quote for

PDF Report for CELG

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CELG Pro Report PDF
Advertisement

Portfolio Strategies Featuring CELG

Did Celgene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CELG Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.celgene.com
  • IR Website: http://ir.celgene.com/
  • HQ Country: United States
  • HQ State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

CELG Excel Add-In Codes

  • Name: =YCI("CELG","name")
  • Description: =YCI("CELG","description")
  • Sector: =YCI("CELG","sector")
  • Industry: =YCI("CELG","industry")
  • Est. Current Fiscal Year End: =YCI("CELG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.